# A Study to Evaluate Retisert in the Treatment of Patients With the "Wet" Form of Age-Related Macular Degeneration

> **NCT00032396** · PHASE2 · UNKNOWN · sponsor: **Control Delivery Systems**

## Conditions studied

- Macular Degeneration

## Interventions

- **DRUG:** Retisert Implant

## Key facts

- **NCT ID:** NCT00032396
- **Lead sponsor:** Control Delivery Systems
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2001-11
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2006-05-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00032396

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00032396, "A Study to Evaluate Retisert in the Treatment of Patients With the "Wet" Form of Age-Related Macular Degeneration". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00032396. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*